We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

158 hedge funds and large institutions have $898M invested in Collegium Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less capital invested

Capital invested by funds: $900M → $898M (-$2.6M)

1.58% less ownership

Funds ownership: 109.35% → 107.77% (-1.6%)

3% less funds holding

Funds holding: 163 → 158 (-5)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

88% less call options, than puts

Call options by funds: $2K | Put options by funds: $16K

Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
61
Reduced
43
Closed
20
Calls
$2K
Puts
$16K
Net Calls
-$14K
Net Calls Change
-$1M

Top Buyers

1
Principal Financial Group
Principal Financial Group
Iowa
+$7.48M
2
EAM
Eventide Asset Management
Massachusetts
+$4.66M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.47M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$4.37M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$3.96M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$17.5M
2
SAM
Silvercrest Asset Management
New York
-$5.3M
3
BlackRock
BlackRock
New York
-$5.08M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.16M
5
RHJA
Rice Hall James & Associates
California
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$134M -$5.08M -219,909 -4%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$96.7M +$351K +15,174 +0.4%
EAM
3
Eventide Asset Management
Massachusetts
$62.2M +$4.66M +201,617 +8%
RCMNY
4
Rubric Capital Management (New York)
New York
$57.2M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$53M +$1.25M +54,009 +2%
CCM
6
Camber Capital Management
Massachusetts
$47.3M – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$29.5M -$374K -16,200 -1%
State Street
8
State Street
Massachusetts
$27.3M +$1.34M +58,221 +5%
Principal Financial Group
9
Principal Financial Group
Iowa
$24.4M +$7.48M +323,854 +46%
PA
10
Perceptive Advisors
New York
$23.1M – – –
Invesco
11
Invesco
Georgia
$23M +$977K +42,286 +5%
RSCM
12
Rock Springs Capital Management
Maryland
$21.7M – – –
GPP
13
Great Point Partners
Connecticut
$20.4M – – –
Massachusetts Financial Services
14
Massachusetts Financial Services
Massachusetts
$19.7M +$4.37M +189,232 +29%
RHJA
15
Rice Hall James & Associates
California
$18.9M -$2.92M -126,530 -14%
EMFAT
16
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.7M – – –
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$18.3M +$4.47M +193,468 +33%
EA
18
Emerald Advisers
Pennsylvania
$17.5M -$177K -7,660 -1%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$14.7M +$830K +35,927 +6%
Northern Trust
20
Northern Trust
Illinois
$10.2M -$140K -6,059 -1%
MFIMFI
21
Mesirow Financial Investment Management - Fixed Income
Illinois
$9.84M -$228K -9,875 -2%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$8.59M -$649K -28,105 -7%
Morgan Stanley
23
Morgan Stanley
New York
$7.07M -$2.3M -99,372 -25%
Charles Schwab
24
Charles Schwab
California
$6.99M +$1.39M +60,294 +26%
N
25
Nuveen
North Carolina
$6.94M +$607K +26,265 +10%
1
2 3 4 5

COLL Hedge Fund Activity: Q2 2021 in Review

158 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2021, worth a combined $898M — down 0.29% from $900M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of COLL and 17 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 61 added.

The largest buyer was Principal Financial Group, adding an estimated $7.48M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $17.5M sold.

  • 158 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2021, down from 163 in Q1 2021.
  • Funds reported $898M of Collegium Pharmaceutical stock for Q2 2021, down 0.29% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2021 and 20 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2021 was Principal Financial Group, an estimated $7.48M added.
  • The largest Collegium Pharmaceutical seller in Q2 2021 was Avidity Partners Management, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2021.